Loading
Iceland's medicines regulator. It authorises medicines and clinical trials, monitors side effects, and decides the maximum prices and public reimbursement of prescription medicines.
Lyfjastofnun is an independent agency under Iceland's Ministry of Health with about 70 staff. It grants marketing authorisations, supervises the manufacture, distribution and sale of medicines, handles adverse reaction reports, authorises clinical trials of medicinal products, supervises advertising and publishes the Register of Medicinal Products; it works within the European Medicines Agency's network of agencies in the European Economic Area. It also sets the maximum prices of prescription-only medicines and decides on their reimbursement under the Medicinal Products Act, publishing the Icelandic Medicine Price Catalogue monthly. Its address is Vínlandsleið 14, Reykjavík; the coordinates are the OpenStreetMap point for the building.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/